News Releases Month Year Su Mo Tu We Th Fr Sa 25 26 27 28 29 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1 2 3 4 5 Cancel Go Month Year Su Mo Tu We Th Fr Sa 25 26 27 28 29 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1 2 3 4 5 Cancel Go Email Alerts Year All Years 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 Keywords Go Advanced Search Keywords Search Headlines Only From To Asset Types Photos Video Audio Documents Events Standard Nov 5, 2007 Insmed Announces Initiation of Phase II Clinical Trial with IPLEX(TM) in Myotonic Muscular Dystrophy Oct 24, 2007 Insmed Announces Third Quarter Earnings Release Date and Conference Call Oct 23, 2007 Insmed to Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference Oct 3, 2007 Insmed to Present at the 2007 BIO Investor Forum on Wednesday, October 10, 2007 Aug 2, 2007 Insmed Reports Financial Results for Second Quarter and First Half of 2007 Jul 25, 2007 Insmed Announces Second Quarter and First Half Earnings Release Date and Conference Call Jul 9, 2007 Insmed Inc. to Present at C.E. Unterberg, Towbin Growth Conference Jun 26, 2007 Insmed Inc. Welcomes Studies Linking IGFBP-3 to Prevention of Blindness in Premature Infants Jun 25, 2007 Experienced Biopharmaceutical Executive Steve Glover Joins Insmed; Will Lead Development of Follow-on Biologics Jun 19, 2007 Insmed Receives NASDAQ Deficiency Notice Relating to Minimum Bid Price Show 5102550100 per page«1…47484950515253…69» Stay In The Loop Want to stay up to date on our news, events, and filings? Set up your email alerts. Sign Up View the latest Insmed Investor Presentation Download